Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Cost of Revenue (2016 - 2023)

Historic Cost of Revenue for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to $181000.0.

  • Cellectis' Cost of Revenue fell 5068.12% to $181000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.3 million, marking a year-over-year decrease of 483.38%. This contributed to the annual value of $1.8 million for FY2022, which is 390.46% down from last year.
  • According to the latest figures from Q3 2023, Cellectis' Cost of Revenue is $181000.0, which was down 5068.12% from $55000.0 recorded in Q2 2023.
  • Over the past 5 years, Cellectis' Cost of Revenue peaked at $18.6 million during Q4 2020, and registered a low of $55000.0 during Q2 2023.
  • Moreover, its 5-year median value for Cost of Revenue was $815000.0 (2019), whereas its average is $4.2 million.
  • As far as peak fluctuations go, Cellectis' Cost of Revenue soared by 68500.0% in 2019, and later plummeted by 9869.66% in 2021.
  • Cellectis' Cost of Revenue (Quarter) stood at $5.7 million in 2019, then surged by 229.87% to $18.6 million in 2020, then tumbled by 98.7% to $243000.0 in 2021, then skyrocketed by 183.95% to $690000.0 in 2022, then plummeted by 73.77% to $181000.0 in 2023.
  • Its last three reported values are $181000.0 in Q3 2023, $55000.0 for Q2 2023, and $334000.0 during Q1 2023.